Dr. Gold is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
660 S Euclid Ave
Saint Louis, MO 63110Phone+1 314-362-5000
Summary
- Dr. Mark S. Gold is an inventor, Psychiatrist, Distinguished Professor, Chairman, pioneering translational and new treatment researcher. Gold hypothesized rebound hyperactivity in locus coeruleus and then proved clonidine efficacy in opiate withdrawal .His research has changed health care delivery allowing new detox options, pain treatments, abstinence, and naltrexone maintenance focusing on relapse prevention . Gold and colleagues hypothesized that cocaine caused a relative dopamine deficiency. Gold showed cocaine was addicting , identified the cocaine-dopamine connection accompanied by anhedonia. As a Professor, Eminent Scholar, Distinguished Professor, and Chairman Gold pioneered the study of smoke vs drug self administration leading to clearer understanding of second hand tobacco, opium, and cannabis smoking . Gold's groundbreaking work in Afghanistan on children of opium smokers was recently published in Lancet. Gold started the Division of Addiction Medicine, and Florida's Recovery Center . Gold and Colleagues at Princeton University defined addiction liability of sugar and hedonic overeating . This model has allowed for development of new treatments for overeating based on addiction treatments.ASAM presented Gold with the John P. McGovern " Annual Award on Addiction & Society "... for numerous highly meritorious contributions ". Gold received the PATH Lifetime Achievement Award (2016) in NYC with Obama Drug Czar Botticelli, commending Gold for" Lifetime" pioneering work in MAT, prevention, education and training. According to a review in the Journal of the American Medical Association (JAMA 272:18, 1996), "Mark S. Gold, M.D. the most prolific and brilliant of the addiction experts writing today. Dr. Gold has spent his career trying to bridge the gap in medical education and practice with the belief that addictions are diseases and that all physicians have a critical role in prevention and, if that fails, in early identification and prompt treatment."
Clinical Expertise
- Clinical research, Psychopharmacology, Anxiety disorders, Depression, Addiction psychiatry, Addiction medicine, Alcoholism, Marijuana abuse, Heroin dependence, Mental disorders, Feeding and eating disorders, Opioid-related disorders, https://www.addictionpolicy.org/research-you-can-use
Education & Training
- Yale-New Haven Medical CenterChief Residency, Psychiatry, 1978 - 1978
- Yale-New Haven Medical CenterResidency, Psychiatry, 1975 - 1978
- University of Florida College of MedicineClass of 1975
Certifications & Licensure
- FL State Medical License 1981 - 2023
- NY State Medical License 1980 - 2015
Awards, Honors, & Recognition
- University of Florida College of Medicine Wall of Fame
- Phi Beta Kappa
- Alpha Omega Alpha
- Join now to see all
Publications & Presentations
PubMed
- In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicide ...Alireza Sharafshah, Kai-Uwe Lewandrowski, Mark S Gold, Brian Fuehrlein, J Wes Ashford
Current Neuropharmacology. 2025-01-24 - Evidence Based Clinical Analytics Supporting the Genetic Addiction Risk Severity (GARS) Assessment to Early Identify Probands in Preaddiction.Kenneth Blum, Abdalla Bowirrat, Panayotis K Thanos, Colin Hanna, Jag Khalsa
EC Psychology and Psychiatry. 2024-12-26 - The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Comp...Kenneth Blum, Igor Elman, David Han, Colin Hanna, David Baron
Open Journal of Immunology. 2024-09-01
Books/Book Chapters
Lectures
- Northeast Conference on Behavioral Health and Addictive Disorders - Trauma, Addiction & RelationshipsU.S. Journal Training Inc, New Brunswick, New Jersey - 9/12/2012
Other
- Make a difference in the current opioid crisisMark Gold, Psychology Today
https://www.psychologytoday.com/intl/blog/addiction-outlook/202402/key-addiction-points-you-need-to-know
2/18/2024 - Life or Death : Stigma impedes treatment access for many with opioid use dependenceMark Gold, Psychology Today
https://www.psychologytoday.com/us/blog/addiction-outlook/202402/life-or-death
2/1/2024 - Addiction Research You Can UseMark Gold
https://www.addictionpolicy.org/research-you-can-use
Authored Content
- Medication-Assisted Treatment for Opioid-Use Disorder.October 2019
Press Mentions
- America’s Geriatric STD Crisis Exposed: The States Where Seniors Have the Most Unprotected SexSeptember 18th, 2024
- Scientists Uncover Possible Neural Link Between Early Life Trauma and Binge-Eating DisorderDecember 12th, 2022
- Mark Gold, Groundbreaking Researcher and Pioneer of Medication Assisted Recovery, Joins Board of Directors at Spero HealthDecember 2nd, 2019
- Join now to see all
Professional Memberships
- Fellow
- Fellow
- Member
External Links
- Dr. Mark Goldhttp://www.drmarkgold.com
- Linked Inhttps://www.linkedin.com/in/mark-gold-68366aa0/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: